Literature DB >> 17101832

Cardiac and pulmonary investigations in Bethlem myopathy.

Anneke J van der Kooi1, Willem G de Voogt, Enrico Bertini, Luciano Merlini, F Beril Talim, Rabah Ben Yaou, Andoni Urtziberea, Marianne de Visser.   

Abstract

BACKGROUND: Bethlem myopathy is considered a relatively mild neuromuscular disorder without significant cardiac and respiratory involvement.
OBJECTIVE: To investigate cardiac and respiratory involvement in Bethlem myopathy.
DESIGN: Cross-sectional study.
SETTING: University hospitals. Patients Fifty patients with Bethlem myopathy from 26 families.
INTERVENTIONS: Cardiac examinations, including electrocardiography and echocardiography (n = 37) and pulmonary investigations (n = 43). Holter monitoring was performed in 16 patients. MAIN OUTCOME MEASURES: Cardiac and respiratory abnormalities.
RESULTS: Several cardiac abnormalities were found that were considered unrelated to the muscular disorder. Seven (16%) of 43 patients had a forced vital capacity less than 70% of the predicted value. One of 2 patients with a forced vital capacity less than 50% was also receiving respiratory support. All patients with compromised respiratory function were still ambulatory, and we found no significant correlation between the severity of arm weakness and the severity of respiratory muscle involvement.
CONCLUSIONS: There is no evidence of cardiac involvement in Bethlem myopathy. Respiratory failure is part of the clinical spectrum and can occur in ambulatory patients.

Entities:  

Mesh:

Year:  2006        PMID: 17101832     DOI: 10.1001/archneur.63.11.1617

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  15 in total

1.  Annexin A2 mediates secretion of collagen VI, pulmonary elasticity and apoptosis of bronchial epithelial cells.

Authors:  Maryann Dassah; Dena Almeida; Rebecca Hahn; Paolo Bonaldo; Stefan Worgall; Katherine A Hajjar
Journal:  J Cell Sci       Date:  2013-12-19       Impact factor: 5.285

Review 2.  The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.

Authors:  Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2019-06-20       Impact factor: 17.367

Review 3.  Joint hypermobility as a distinctive feature in the differential diagnosis of myopathies.

Authors:  N C Voermans; C G Bonnemann; B C J Hamel; H Jungbluth; B G van Engelen
Journal:  J Neurol       Date:  2009-02-09       Impact factor: 4.849

Review 4.  Therapy of collagen VI-related myopathies (Bethlem and Ullrich).

Authors:  Luciano Merlini; Paolo Bernardi
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

5.  Congenital myopathies are mainly associated with a mild cardiac phenotype.

Authors:  Helle Petri; Karim Wahbi; Nanna Witting; Lars Køber; Henning Bundgaard; Emna Kamoun; Geoffroy Vellieux; Tanya Stojkovic; Anthony Béhin; Pascal Laforet; John Vissing
Journal:  J Neurol       Date:  2019-03-14       Impact factor: 4.849

6.  Sarcopenia and sarcopenic obesity in patients with muscular dystrophy.

Authors:  Luciano Merlini; Alessandro Vagheggini; Daniela Cocchi
Journal:  Front Aging Neurosci       Date:  2014-10-07       Impact factor: 5.750

7.  Genetic Complexity of Mitral Valve Prolapse Revealed by Clinical and Genetic Evaluation of a Large Family.

Authors:  Gloria T Haskell; Brian C Jensen; Cecile Skrzynia; Thelsa Pulikkotil; Christian R Tilley; Yurong Lu; Daniel S Marchuk; Leigh Ann Samsa; Kirk C Wilhelmsen; Ethan Lange; Cam Patterson; James P Evans; Jonathan S Berg
Journal:  J Heart Valve Dis       Date:  2017-09

8.  A Novel Variant of COL6A2 Gene Causing Bethlem Myopathy and Evaluation of Essential Hypertension.

Authors:  M Gultekin Kutluk; Naz Kadem; Omer Bektas; Nadide Cemre Randa; Gökcen Oz Tuncer; Pelin Albayrak; Tuba Eminoglu; Serap Tiras Teber
Journal:  Ann Indian Acad Neurol       Date:  2020-09-02       Impact factor: 1.383

9.  Body composition, muscle strength, and physical function of patients with Bethlem myopathy and Ullrich congenital muscular dystrophy.

Authors:  Maria Teresa Miscione; Francesca Bruno; Claudio Ripamonti; Giuliana Nervuti; Riccardo Orsini; Cesare Faldini; Massimo Pellegrini; Daniela Cocchi; Luciano Merlini
Journal:  ScientificWorldJournal       Date:  2013-09-12

10.  A TALEN-Exon Skipping Design for a Bethlem Myopathy Model in Zebrafish.

Authors:  Zlatko Radev; Jean-Michel Hermel; Yannick Elipot; Sandrine Bretaud; Sylvain Arnould; Philippe Duchateau; Florence Ruggiero; Jean-Stéphane Joly; Frédéric Sohm
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.